Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
- PMID: 17874073
- DOI: 10.1007/s00213-007-0930-9
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
Abstract
Rationale: Binocular rivalry occurs when different images are simultaneously presented to each eye. During continual viewing of this stimulus, the observer will experience repeated switches between visual awareness of the two images. Previous studies have suggested that a slow rate of perceptual switching may be associated with clinical and drug-induced psychosis.
Objectives: The objective of the study was to explore the proposed relationship between binocular rivalry switch rate and subjective changes in psychological state associated with 5-HT2A receptor activation.
Materials and methods: This study used psilocybin, the hallucinogen found naturally in Psilocybe mushrooms that had previously been found to induce psychosis-like symptoms via the 5-HT2A receptor. The effects of psilocybin (215 microg/kg) were considered alone and after pretreatment with the selective 5-HT2A antagonist ketanserin (50 mg) in ten healthy human subjects.
Results: Psilocybin significantly reduced the rate of binocular rivalry switching and increased the proportion of transitional/mixed percept experience. Pretreatment with ketanserin blocked the majority of psilocybin's "positive" psychosis-like hallucinogenic symptoms. However, ketanserin had no influence on either the psilocybin-induced slowing of binocular rivalry or the drug's "negative-type symptoms" associated with reduced arousal and vigilance.
Conclusions: Together, these findings link changes in binocular rivalry switching rate to subjective levels of arousal and attention. In addition, it suggests that psilocybin's effect on binocular rivalry is unlikely to be mediated by the 5-HT2A receptor.
Similar articles
-
Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Neuropsychopharmacology. 2005 Jun;30(6):1154-62. doi: 10.1038/sj.npp.1300621. Neuropsychopharmacology. 2005. PMID: 15688092 Clinical Trial.
-
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.J Cogn Neurosci. 2005 Oct;17(10):1497-508. doi: 10.1162/089892905774597191. J Cogn Neurosci. 2005. PMID: 16269092 Clinical Trial.
-
Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.Biol Psychiatry. 2012 Dec 1;72(11):898-906. doi: 10.1016/j.biopsych.2012.04.005. Epub 2012 May 10. Biol Psychiatry. 2012. PMID: 22578254 Clinical Trial.
-
How does binocular rivalry emerge from cortical mechanisms of 3-D vision?Vision Res. 2008 Sep;48(21):2232-50. doi: 10.1016/j.visres.2008.06.024. Epub 2008 Aug 13. Vision Res. 2008. PMID: 18640145 Review.
-
Psilocybin--summary of knowledge and new perspectives.Eur Neuropsychopharmacol. 2014 Mar;24(3):342-56. doi: 10.1016/j.euroneuro.2013.12.006. Epub 2013 Dec 17. Eur Neuropsychopharmacol. 2014. PMID: 24444771 Review.
Cited by
-
A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.Brain Sci. 2024 Mar 3;14(3):248. doi: 10.3390/brainsci14030248. Brain Sci. 2024. PMID: 38539636 Free PMC article. Review.
-
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Front Neuroergon. 2022 Jan 20;2:784576. doi: 10.3389/fnrgo.2021.784576. eCollection 2021. Front Neuroergon. 2022. PMID: 38235248 Free PMC article.
-
Drug-drug interactions involving classic psychedelics: A systematic review.J Psychopharmacol. 2024 Jan;38(1):3-18. doi: 10.1177/02698811231211219. Epub 2023 Nov 20. J Psychopharmacol. 2024. PMID: 37982394 Free PMC article. Review.
-
Bistable perception, precision and neuromodulation.Cereb Cortex. 2024 Jan 14;34(1):bhad401. doi: 10.1093/cercor/bhad401. Cereb Cortex. 2024. PMID: 37950879 Free PMC article.
-
Psilocybin's effects on cognition and creativity: A scoping review.J Psychopharmacol. 2023 Jul;37(7):635-648. doi: 10.1177/02698811231179801. Epub 2023 Jul 3. J Psychopharmacol. 2023. PMID: 37395359 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources